These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 7239268

  • 21. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY, Neff NH.
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Monoamine and diamine oxidative deamination in the longitudinal smooth muscle of guinea pig ileum.
    Banchelli G, Raimondi L, Ignesti G, Pirisino R, Buffoni F.
    Med Biol; 1985 Jun; 63(1):34-9. PubMed ID: 3999819
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Formation of the superoxide anion radical during the oxidation of biogenic amines catalyzed by mitochondrial monoamine oxidase].
    Volkovitskaia OE, Bochev PG, Ribarev SR, Gorkin VZ, Kagan VE.
    Biull Eksp Biol Med; 1986 Dec; 102(12):687-9. PubMed ID: 3026510
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Amine binding with mitochondrial monoamine oxidase and the selective inhibition of enzymatic activity by pyridine derivatives].
    Severina IS, Kozlova IS.
    Biokhimiia; 1973 Dec; 38(5):1076-82. PubMed ID: 4780966
    [No Abstract] [Full Text] [Related]

  • 29. [Deamination of some biogenic monoamines and succinate dehydrogenase activity in mitochondria].
    Gorkin VZ, Krivchenkova RS.
    Vopr Med Khim; 1971 Dec; 17(1):65-73. PubMed ID: 5555147
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Catalytic properties of monoamine oxidases during adaptation to altitude chamber hypoxia].
    Shatemirova KK, Zelenshchikova VA, Min'ko IuV.
    Kosm Biol Aviakosm Med; 1990 Dec; 24(2):54-6. PubMed ID: 2366506
    [Abstract] [Full Text] [Related]

  • 34. [Importance of initial monoamine oxidase activity to the development of the activating or inhibitory effect of N-methyl- and N-ethyloctahydronaphthoazepines].
    Safrazbekian RR, Sukasian RS.
    Vopr Med Khim; 1980 Dec; 26(2):240-3. PubMed ID: 7456355
    [Abstract] [Full Text] [Related]

  • 35. [Mechanism of the pharmacological effect of monoamine oxidase inhibitors].
    Gorkin VZ.
    Vestn Akad Med Nauk SSSR; 1984 Dec; (11):72-5. PubMed ID: 6396999
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Substrate specificity of monoamine oxidase from the brain and liver of the human fetus during antenatal ontogenesis].
    Skorobogataia TG.
    Ukr Biokhim Zh (1978); 1986 Dec; 58(2):81-3. PubMed ID: 3705207
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Further studies on the inhibition of monoamine oxidation by monoamine oxidase inhibitors.
    Ghosh SK, Guha SR.
    Biochem Pharmacol; 1978 Jan 01; 27(1):112-4. PubMed ID: 619893
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.